She is a 30-year veteran of the biotechnology industry, the last 20 in cell and gene therapy. Ms. Hagen is co-founder of Vineti, a cloud-based software platform company that addresses challenges in data management from order through cell collection, manufacturing, and delivery of personalized treatments such as cell and gene therapies and cancer vaccines. She has extensive experience in operations management and commercializing innovative technologies. She is also the former Global COO for SOTIO a.s. and the Senior Vice President of Operations for Dendreon. Ms. Hagen has a B.S. in Cell and Molecular Biology, an MS in Bioengineering, and an MBA from the University of Washington.